IRIS
MARZIO, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.961
EU - Europa 5.561
AS - Asia 5.514
SA - Sud America 618
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 9
Totale 19.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.838
SG - Singapore 2.022
CN - Cina 1.605
UA - Ucraina 976
IE - Irlanda 781
IT - Italia 760
TR - Turchia 702
SE - Svezia 642
RU - Federazione Russa 601
GB - Regno Unito 588
BR - Brasile 505
VN - Vietnam 458
FR - Francia 454
IN - India 421
DE - Germania 351
FI - Finlandia 209
CA - Canada 66
BD - Bangladesh 64
PL - Polonia 60
HK - Hong Kong 44
MX - Messico 40
AR - Argentina 35
IQ - Iraq 32
EC - Ecuador 29
KR - Corea 27
ZA - Sudafrica 22
ES - Italia 20
ID - Indonesia 19
JP - Giappone 19
BE - Belgio 17
EU - Europa 17
NL - Olanda 15
RO - Romania 15
CO - Colombia 14
PK - Pakistan 13
CZ - Repubblica Ceca 12
PY - Paraguay 12
LT - Lituania 11
MA - Marocco 11
AT - Austria 10
GR - Grecia 10
IL - Israele 10
UZ - Uzbekistan 10
AU - Australia 9
CL - Cile 8
DZ - Algeria 8
KE - Kenya 8
SA - Arabia Saudita 8
JO - Giordania 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
AL - Albania 5
AZ - Azerbaigian 5
IR - Iran 5
PE - Perù 5
PH - Filippine 5
ET - Etiopia 4
PS - Palestinian Territory 4
PT - Portogallo 4
VE - Venezuela 4
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
JM - Giamaica 3
MD - Moldavia 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
SC - Seychelles 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MG - Madagascar 1
MN - Mongolia 1
RE - Reunion 1
RS - Serbia 1
Totale 19.744
Salva come PNG Salva come JPEG
Città #
Singapore 1.344
Jacksonville 1.079
San Jose 803
Chandler 779
Dublin 768
Dearborn 458
Southend 422
Ashburn 405
Princeton 386
Dallas 349
Izmir 333
Beijing 328
Nanjing 327
Wilmington 257
Council Bluffs 223
Los Angeles 205
Cambridge 181
Ho Chi Minh City 159
Tongling 135
Buffalo 125
New York 123
Santa Clara 118
Woodbridge 118
Ann Arbor 113
The Dalles 110
Nanchang 104
Hanoi 95
Boardman 65
Houston 65
Moscow 64
Shenyang 62
Hebei 56
Altamura 54
São Paulo 54
Rome 51
Munich 50
Kunming 49
Hefei 48
Tianjin 46
Jiaxing 44
Kraków 36
Redondo Beach 36
Chieti 35
Hong Kong 35
Milan 34
Hangzhou 33
Da Nang 29
Bologna 26
Jinan 26
Norwalk 24
Brooklyn 23
London 23
Grevenbroich 22
Guangzhou 22
Boston 20
Dong Ket 20
Orange 20
Warsaw 20
Changsha 19
Guayaquil 19
Seoul 19
Haiphong 18
Helsinki 18
Tokyo 18
Toronto 18
Washington 18
Denver 17
Frankfurt am Main 17
Orem 17
Brussels 16
Rio de Janeiro 16
Stockholm 16
Düsseldorf 15
Montreal 15
Augusta 14
Belo Horizonte 14
Brasília 14
Chennai 14
Chicago 14
Johannesburg 14
Seattle 14
Turku 14
Vinh 14
San Francisco 13
Atlanta 12
Baghdad 12
Changchun 12
Charlotte 12
Lanzhou 12
Hải Dương 11
Pescara 11
Phoenix 11
San Mateo 11
Ankara 10
Ningbo 10
Cepagatti 9
Curitiba 9
Fuzhou 9
Guadalajara 9
Mexico City 9
Totale 11.623
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 404
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 299
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 189
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 172
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 171
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 167
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 167
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 167
Antibacterial effect of plant extracts against Helicobacter pylori 165
24-hour pancolonic motility using a portable electronic probe in healthy subjects 162
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 162
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 155
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 153
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 151
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 150
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 149
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 149
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 145
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 145
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 141
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 141
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 141
Trasmissione di Helicobacter pylori in un modello murino 140
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 140
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 139
Cigarette smoke, ferritin, and lipid peroxidation 139
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 139
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 137
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 136
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 136
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 135
Heightened free radical activity in angina pectoris 134
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 134
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 133
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 133
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 132
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 132
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 131
L'eritromicina accelera lo svuotamento gastrico e colecistico nell'uomo attraverso un meccanismo mediato dall'acetilcolina 130
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 130
Detection of Helicobacter pylori in saliva and esophagus 129
[Physiopathological bases of the medical treatment of portal hypertension]. 129
Prolonged anal sphincter manometry in normal human subjects 127
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 127
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 127
Heparin: does it act as an antioxidant in vivo? 126
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 125
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 125
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 125
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 124
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 123
Detection of Helicobacter pylori in esophagus and saliva in humans 123
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 122
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 122
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 121
Masse all'ipocondrio dx e carcinoma della colecisti 120
Erythromycin accellerates gastric and gallbladder emptying through a cholinergic mediated mechanism in humans 120
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 119
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 118
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 118
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 118
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 117
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 117
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 116
Glutathione peroxidase, glutathione reductase and glutathione transferase activities in the human artery, vein and heart. 116
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 116
PRUCALOPRIDE INCREASES BASAL LES TONE IN PATIENTS WITH ESOPHAGEAL MOTILITY DISORDERS 115
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 114
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 112
Esophageal and gastric motility in patients with gastroesophageal reflux disease 111
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 111
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 111
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 111
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 110
Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori 110
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 109
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 109
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies 109
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 108
Registrazione delle 24 ore della motilità del piloro in soggetti normali 107
La terapia chirurgica laparoscopica della malattia da reflusso gastro-esofageo 107
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 107
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 107
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 107
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 107
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 106
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 105
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 105
Proximal and Distal Gastric Distension in Normal Subjects and H. pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 104
Influence of physical activity on gastric emptying of liquids in normal human subjects 104
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 103
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 103
Role of nitric oxide on peristaltic motor activity in an in vitro rabbit intestinal preparation 103
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 102
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 102
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 102
Relationship between interdigestive esophageal and gastric motility in humans 102
EVALUATION OF INTRA PARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSIS BY FIBROSCAN IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPARISON WITH NORMAL CONTROLS 102
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 101
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 100
Totale 13.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.277
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 0 0 77
2021/2022794 28 12 6 200 75 9 10 65 55 6 89 239
2022/20232.220 199 234 122 268 186 514 150 160 259 29 54 45
2023/20241.019 77 52 65 29 33 313 252 40 3 41 17 97
2024/20252.642 189 410 308 38 65 67 48 161 335 110 279 632
2025/20265.613 466 278 668 697 468 367 818 437 563 429 382 40
Totale 20.007